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Abstract To assessthe diagnosticvalue ofadenosine
‘‘stress-only’’ myocardial perfusion MR for ischemia
detection as an indicator for coronary angiography in
patients without a prior myocardial infarction and a
necessity to exclude ischemia. Adenosine perfusion
MRI was performed at 1.5 T in 139 patients with a
suspicion of ischemia and no prior myocardial infarc-
tion. After 3 min of adenosine infusion a perfusion
sequence was started. Patients with a perfusion defect
were referred to coronary angiography (CAG). Patients
with a normal perfusion were enrolled in follow-up.
Fourteen out of 139 patients (10.1%) had a perfusion
defectindicative ofischemia.Thesepatientsunderwent
a coronary angiogram, which showed complete agree-
ment with the perfusion images. 125 patients with a
normal myocardial perfusion entered follow-up (med-
ian 672 days, range 333–1287 days).Inthe ﬁrstyearof
follow-uponeMajorAdverseCoronaryEvent(MACE)
occurred and one patient had new onset chest pain with
a conﬁrmed coronary stenosis. Reaching a negative
predictive value for MACE of 99.2% and for any
coronary event of 98.4%. At 2 year follow-up no
additional MACE occurred. Sensitivity of adenosine
perfusion MR for MACE is 93.3% and speciﬁcity and
positive predictive value are 100%. Adenosine myo-
cardial perfusion MR for the detection of myocardial
ischemia in a ‘‘stress-only’’ protocolin patientswithout
prior myocardial infarctions, has a high diagnostic
accuracy. This fast examination can play an important
role in the evaluation of patients without prior myocar-
dial infarctions and a necessity to exclude ischemia.
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Introduction
Adenosine ‘‘stress’’ MR myocardial perfusion imag-
ing has a proven high sensitivity and negative
predictive value for the detection of myocardial
ischemia [1–12]. High diagnostic accuracies are
reached in patient groups with relatively high
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perfusion and delayed contrast enhancement. For the
subgroup of patients with a history of myocardial
infarction these elaborate protocols or different stress
MR imaging methods are probably most appropriate.
In relatively lower risk patients, those without known
myocardial infarction, less comprehensive protocols
may be sufﬁcient to guide further work-up and
therapy choice. In lower-risk patient groups exam-
ined by adenosine ‘‘stress-only’’ perfusion MR
imaging the number of purely diagnostic Coronary
angiographies (CAG’s) might thus be reduced, which
would be important because CAG is an invasive test
with a risk of complications and relatively expensive.
Furthermore, taking into account that PCI with stent
implantation is not harmless, invasive treatment
should only be reserved for those patients with
objectiﬁed myocardial ischemia [13, 14]. A non-
invasive imaging technique such as an appropriately
designed MR protocol, can be used as an indicator to
determine which patients need to be directed to
coronary angiography. With the routine implementa-
tion of adenosine perfusion MR still lagging behind,
we sought to tailor a protocol designed for a speciﬁc
population.
Directing the patient to the proper MR stress
perfusion test or protocol, could yield diagnostic gain
and time savings allowing analysis of larger patient
groups.
In this study, the prognosis after a negative
adenosine perfusion MR examination and the diag-
nostic accuracy of adenosine ‘‘stress’’myocardial
perfusion MR were examined in a stress-only
approach, in patients without prior myocardial infarc-
tion and a clinical necessity to exclude myocardial
ischemia.
Methods
Patient population
150 consecutive patients referred between January
2005 to April 2006 from the outpatient clinic of the
department of Cardiology for an adenosine perfusion
MR, were included. Eleven patients were not enrolled
in the ﬁnal study population due to a history of
myocardial infarction (3 patients), use of vasoactive
medication during adenosine (2 patients), moving out
of the country with loss of follow-up (3 patients) and
refused consent (3 patients). The ﬁnal study popula-
tion therefore consisted of 139 prospectively enrolled
patients. The study was approved by the medical
ethical board. Pre-test likelihood of these patients was
determined according to a classiﬁcation for chronic
stable chest pain by Gibbons et al. [15]. Patients who
could not be determined according to this classiﬁca-
tion were stratiﬁed with a calcium score (22 patients,
mean calcium score 220 (±322)) or considered to be
at intermediate risk (for example rhythm abnormal-
ities). Patients with a calciumscore [90th percentile
were considered to be at intermediate risk. Further-
more the percentage of patients with: hypertension,
diabetes, smoking history, positive family history for
coronary artery disease (CAD) and hypercholesterol-
emia and summary values on age, gender distribution,
body weight and Body Mass Index (BMI) are
displayed in Table 1.
Patients with a perfusion defect were referred for
CAG. Patients with a normal adenosine perfusion
examination had clinical follow-up for at least 1 year.
Adenosine perfusion MR
All anti-anginal medication was stopped 4 days
before the adenosine perfusion MR examination.
Xhantine containing products like coffee, tea, choc-
olate, cola had to be stopped 24 h prior to the
examination. Dypiridamol had to be stopped or was
considered a contra-indication. Scanning was per-
formed at 1.5 T using a magnetom Avanto MRI
system (Siemens Medical Solutions, Erlangen,
Germany). After the patient was positioned on the
scanning table, intravenous access was established
via an anticubital vein. Vector ECG monitoring leads,
a 12 channel phased-array surface coil covering the
heart, and a brachial blood pressure cuff were
applied. A single lead ECG signal was continuously
monitored on the MRI-console. Systolic and diastolic
blood pressures and heart rate were recorded at
baseline and during adenosine infusion.
After 3 min of adenosine infusion (0.140 mg/kg/
min) during the ﬁrst pass of 0.1 mmol/kg gadopen-
tetate dimeglumine with a ﬂow rate of 5 ml/s ﬂushed
with 15 ml 0.9% NaCL (ﬂow rate 5 ml/s) a noselec-
tive saturation recovery perfusion sequence, with
high SNR, CNR and inline display was started
(typical parameters): TrueFisp: TR, 150.5/163.1 ms
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TI 100/103 ms; a 45/50; FOV 300 9 300; slice-
thickness 6 mm; matrix 76 9 128; iPAT 2. Acquisi-
tion of three short-axis slices. Typical inplane
resolution 2.5 9 2.5 mm. During the examination a
radiologist and a cardiologist were present in the MR
suite, to monitor the condition of the patient and to
evaluate the images immediately. Total duration of
the protocol was approximately 15 min.
Image analysis
Perfusion series were visually analysed by an expe-
rienced radiologist and cardiologist in consensus,
using a 16 segment model [16]. A perfusion abnor-
mality in at least two segments at consecutive planes
of the left ventricle or one segment of the most apical
slice, was used as an indication for CAG. Patients
with a perfusion defect were examined by CAG
within 3 weeks.
Analysis of the coronary angiograms was per-
formed by an experienced cardiologist, blinded to the
MR results. A signiﬁcant coronary lesion was deﬁned
as a narrowing of [50%. The decision for a PCI or
CABG was made in regular consultation with cardiac
surgeons and interventional cardiologists.
Follow-up
Follow-up was completed in October 2008. The
status of the patient was determined by review of
the hospital records, contacting the patient’s general
physician or by a questionnaire after informed
consent. Reported clinical events were conﬁrmed by
contact with the treating hospital. The date of the
hospital visit, last visit to the general physician or the
date of returning the questionnaire was used to
calculate follow-up time.
Patients were observed for occurrence of MACE
(Major Adverse Cardiac Events) and MACE includ-
ing coronary artery revascularization after objectiﬁed
ischemia as composite end point and classiﬁed as
composite MACE. Occurrence of noncardiac mortal-
ity was documented: such cases were censored for
MACE evaluation at the time of death.
Table 1 Demographic and
hemodynamic data
Values are expressed as
mean ± SD, range or
percentage
Variable Mean or %
Age, years, mean 60.7 ± 10.5
Male (%) 54
Body mass index, kg, mean 26.3 ± 3.9
Hypercholesterolaemia (%) 86.1
Hypertension (%) 46.3
Diabetes (%) 14.9
Current smokers (%) 18.8
Former smokers (%) 44.2
Positive family history (%) 52.1
Pre-test likelihood
Very low (%) 2.2
Low (%) 19.4
Intermediate (%) 55.4
High (%) 23.0
Resting diastolic blood pressure, mmHg, mean 83.1 ± 10.2
Diastolic blood pressure under adenosine, mmHg, mean 87.6 ± 10.0
Resting systolic blood pressure, mmHg, mean 153.3 ± 25.2
Systolic blood pressure under adenosine, mmHg, mean 146.4 ± 23.1
Resting heart rate, bpm, mean 76.6 ± 16.0
Heart rate under adenosine, bpm, mean 88.5 ± 17.5
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The aim of this study was to assess the diagnostic
accuracy of an adenosine ‘‘stress-only’’ perfusion MR
examination in patients without a prior myocardial
infarction as a clinical indicator for coronary angi-
ography and to determine the prognosis after a
normal adenosine perfusion MR examination. Con-
ﬁrmation of the adenosine perfusion MR results was
done by detection of a signiﬁcant coronary stenosis
on CAG or with at least 1 year follow-up in case of a
normal adenosine perfusion MR examination.
Statistics
Sensitivity, speciﬁcity, negative and positive predic-
tive values were calculated, with conﬁdence inter-
vals. Baseline characteristics are given as mean or
median with standard deviation or range for contin-
uous variables and as number (%) for categorical
variables.
Results
139 consecutive patients entered the study. Mean age
60.7 ± 10.5, 54% male. Demographic and hemody-
namic data are listed in Table 1. During adenosine
perfusion MR no major adverse reactions were seen
in this patient group.
Fourteen out of 139 patients (10.1%) had a
perfusion abnormality indicative for myocardial
ischemia, Fig. 1. Corresponding CAG displayed in
Fig. 2.
On a per patient basis signiﬁcant coronary artery
disease was demonstrated by CAG in all fourteen
patients, followed by revascularization in 10 patients
(1 CABG, 9 PCI, in 4 patients revascularization was
not feasible).
The 125 patients with a negative (normal) adeno-
sine perfusion MR examination were followed up for
a median period of 672 days (range 333–1,287 days).
There was one MACE during the ﬁrst follow-up year
(0.8%) due to an acute coronary syndrome compli-
cated by ventricular ﬁbrillation, 12 months after the
adenosine perfusion MR examination. There was one
case of new onset chest pain 10 months after the
adenosine perfusion MR examination with subsequent
stent implantation, giving a composite MACE rate of
1.6%. Both patients had a low-pre-test likelihood.
In the second follow-up year two additional
revascularizations were performed (17 and 18 months
after the adenosine perfusion MR and no additional
MACE.
Diagnostic values for sensitivity are 93.3% (CI:
0.68–0.99), speciﬁcity 100% (CI: 0.97–1.00),
Fig. 1 Mid-ventricular short-axis single frame with perfusion
defect in the distribution area of the LCX
Fig. 2 Corresponding LCX stenosis on CAG
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1.00), and Positive Predictive Value (PPV) of 100%
(CI:0.77–1.00).Only6outof32patients(18.8%)with
a high pre-test likelihood had a positive adenosine
perfusion MR examination.
Distribution of the pre-test likelihood of signiﬁcant
coronary artery disease is presented in Table 1.
Discussion
Main results of this study are that prognosis after a
negative adenosine perfusion MR examination is
good in this patient group and justiﬁes conservative
treatment rather than performing an invasive exam-
ination. Second, comparison between positive aden-
osine perfusion MR examinations and CAG is good
on a per patient basis, and could be used in the pre-
selection of patients to be examined by coronary
angiography.
Diagnostic performances reported of adenosine
perfusion MR studies, vary widely depending on the
pulse-sequence, contrast dose, the modality used as a
reference standard, the studied patient population and
the used protocol. Besides this, coronary artery
disease is a progressive disease, which to some
extent explains the relative late occurrence of MACE
or composite MACE after a negative adenosine
perfusion MR in the few patients in this study.
Results should in this regard also be seen as ongoing
disease and not by deﬁnition as a false negative
examination.
For a visual, qualitative approach to adenosine
perfusion MR, one needs an imaging protocol
approach. A good, but extensive approach has been
proposed by Klem et al. [7]. Starting analysis with
delayed contrast imaging, followed by rest and stress
perfusion images. For a speciﬁc population without
prior myocardial infarction we propose an imaging
strategy that focuses on the adenosine stress perfusion
MR series, to answer the question if there is a need
for coronary angiography. In a relatively lower
prevalence population the adenosine perfusion MR
examination can exclude myocardial ischemia in a
large group of patients with a normal adenosine
‘‘stress-only’’ perfusion examination, saving consid-
erable imaging time and thus allowing analysis of
larger patient groups. The importance of this study is
underlined by a recent assessment by Nandalur et al.
[17] that relatively little knowledge is available on
the use of stress perfusion imaging in lower pre-test
probability groups such as in patients without prior
myocardial infarction.
CAG, an invasive, expensive test with a risk of
complications, can in this strategy be reserved for
patients with objectiﬁed ischemia. In this way
adenosine perfusion MR can be used to reduce the
number of pure diagnostic CAG’s.
The few long-term follow-up studies published so
far [1, 12, 18], found good prognosis for a negative
adenosine perfusion MR examinations, results we can
conﬁrm with our study in this patient group. To the
best of our knowledge this is the ﬁrst study to assess
the long term follow-up of an adenosine ‘‘stress-
only’’ approach.
Different imaging modalities can serve as a
gatekeeper for further invasive examinations. Exer-
cise ECG testing results are less accurate than
believed. A meta-analysis of 147 published reports
with in total 24,074 patients reports a mean sensitiv-
ity of exercise ecg-testing of 68% and a mean
speciﬁcity of 77% [15]. Diagnostic accuracy is even
lower when the test is performed only in patients
without a previous myocardial infarction.
Nuclear imaging modalities play an important
role in many centers and a lot of experience and
validation is present, but they do have some
important drawbacks regarding limited spatial and
temporal resolution, attenuation artefacts and the use
of radiation. All issues that can be overcome with
adenosine perfusion MR, but for MR to be able to
compete with nuclear and other stress imaging
modalities, imaging time needs to be short, images
easily interpretable and protocols optimised for the
patient population, taking into account the presence
of a prior myocardial infarction, and the need for
assessment of viable myocardium. On indication a
rest perfusion MR examination or delayed contrast
enhancement can be performed. The optimal popu-
lation for an adenosine perfusion MR examination is
in our opinion found in the patient group without a
prior myocardial infarction. For patients with a prior
myocardial infarction viability imaging may also be
required.
Diagnostic performance of dobutamine stress MR
examinations in this respect has shown good results,
with a good long term prognosis [18–20]. Assess-
ment of viability can be performed in the same
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imaging time signiﬁcantly and may be more reliable
than quantiﬁcation of scar tissue [21]. In a patient
group without prior myocardial infarction absence of
myocardial ischemia can be determined with a
normal, homogeneous, adenosine perfusion MR serie,
with an imaging time of only 15 min.
Some earlier studies have reported moderately
high speciﬁcities, due to the fact that perfusion MR
was not able to discriminate between perfusion
defects caused by ischemia or other causes [2, 10].
Speciﬁcity is probably also high in this study
probably due to examining patients without a prior
history of myocardial infarction and the use of clear
set reading criteria [16].
The use of CAG as a reference standard might be a
limitation, because CAG may be a ‘‘ﬂawed’’gold
standard. CAG fails to account for the effect of diffuse
disease, length of diseased segments and serial stenos-
es, and the functional effects in terms of perfusion for
the myocardium [22]. Higher levels of diagnostic
accuracy are observed when adenosine perfusion MR
was compared with PET [23] or FFR measurements as
the reference standard [24, 25]. Current clinical
practice regarding risk stratiﬁcation and therapy guid-
anceishoweverdirectedbytheCAG,whichmakesita
clinically relevant reference standard.
Rather than performing a quantitative analysis, we
optimized the imaging protocol for a robust, visual
approach. This can be regarded as a limitation, but
previous studies have shown that quantitative and
qualitative, visual assessment of myocardial perfu-
sion to have similar good correlations with CAG [23,
26, 27]. Delayed contrast enhancement imaging or
rest perfusion imaging was not routinely performed.
This may provide additional valuable diagnostic
information, but mostly in a post-infarct setting. This
might therefore be regarded as a limitation, but was a
choice made for a broad application of adenosine
perfusion MR in a speciﬁc population in which we
doubt that it is of additional value. Prior myocardial
infarction, as stated earlier, was used as an exclusion
criterion in this study.
Conclusions
Adenosine perfusion MR, in a ‘‘stress’’-only
approach has a high diagnostic accuracy and may
have a distinct clinical role in patients without
previous myocardial infarctions as an examination
which can reliably determine the necessity for
coronary angiography in a total protocol time of
only 15 min.
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